CAMKK2 and chronic kidney disease: Furthermore, CLMD could increase the phosphorylation levels of the CaMKK2/AMPK pathway in the hippocampus of CKD mice, inhibiting the activation of NF-κB and then down-regulating the release of pro-inflammatory factors in the brain to play a neuroprotective role.